Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments ...

Grail’s cutting-edge cancer blood test has stirred investor excitement many times in the past few years. With the stock down 55% from its February peak, Canaccord Genuity issued a Buy recommendation ...

A single blood draw that can detect 50 different types of cancer sounds like science fiction, but it's already available to ...

A new study finds that fragments of tumor DNA in a patient's bloodstream could show that they are at high risk of a melanoma ...